預後的決定因素 (1年預估死亡率) Determinants of prognosis (estimated 1-year mortality)
|
低風險(<5%) Low risk(<5%)
|
中風險(5–10%) Intermediate risk(5–10%)
|
高風險(>10%) High risk(>10%)
|
右心衰竭的臨床徵象 Clinical signs of right heart failure |
無 Absent
|
無 Absent
|
有 Present
|
症狀惡化 Progression of symptoms |
否 No
|
緩慢 Slow
|
快速 Rapid
|
昏厥 Syncope |
否 No
|
偶爾昏厥 Occasional syncope
|
反覆昏厥 Repeated syncope
|
WHO 活動功能分級 WHO functional class |
I, II
|
III
|
IV
|
六分鐘步行距離 6MWD |
>440公尺 >440 m
|
165–440公尺 165–440 m
|
<165公尺 <165 m
|
心肺運動功能測試 Cardiopulmonary exercise testing |
>Peak VO2 >15 ml/min/kg (>預測值的65%) (>65% pred.) VE/VCO2 slope <36
|
Peak VO2 11–15 ml/min/kg (介於預測值的35–65%) (35–65% pred.) VE/VCO2 slope 36–44.9
|
Peak VO2 <11 ml/min/kg (預測值的<35%) (<35% pred.) VE/VCO2 slope ≥45
|
NT-proBNP 濃度 NT-proBNP plesrns levels |
BNP <50 ng/l NT-proBNP <300 ng/l
|
BNP 50–300 ng/l NT-proBNP 300–1400 ng/l
|
BNP >300 ng/l NT-proBNP >1400 ng/l
|
影像檢查(心臟超音波, 心臟磁振造影) Imaging(echocardiography, CMR imaging) |
右心房面積<18 cm2 沒有心包膜積水 RA area<18 cm2 No or minimal pericardial effusion
|
右心房面積18–26 cm2 沒有或輕微心包膜積 RA area18–26 cm2 No pericardial effusion
|
右心房面積>26 cm2 有心包膜積水 RA area>26 cm2 Pericardial effusion
|
六分鐘步行距離 6MWD |
RAP <8 mmHg CI ≥2.5 l/min/m2 SvO2 >65%
|
RAP 8–14 mmHg CI 2.0–2.4 l/min/m2 SvO2 60–65
|
RAP >14 mmHg CI <2.0 l/min/m2 SvO2<60%
|
預後的決定因素 (1年預估死亡率) Determinants of prognosis (estimated 1-year mortality) |
未完成測驗 |